176 related articles for article (PubMed ID: 38429100)
1. Novel RNA molecular bioengineering technology efficiently produces functional miRNA agents.
Traber GM; Yi C; Batra N; Tu MJ; Yu AM
RNA; 2024 May; 30(6):680-694. PubMed ID: 38429100
[TBL] [Abstract][Full Text] [Related]
2.
Li PC; Tu MJ; Ho PY; Batra N; Tran MML; Qiu JX; Wun T; Lara PN; Hu X; Yu AX; Yu AM
Theranostics; 2021; 11(10):4858-4871. PubMed ID: 33754032
[No Abstract] [Full Text] [Related]
3. Bioengineered miR-34a modulates mitochondrial inner membrane protein 17 like 2 (MPV17L2) expression toward the control of cancer cell mitochondrial functions.
Yi WR; Tu MJ; Yu AX; Lin J; Yu AM
Bioengineered; 2022 May; 13(5):12489-12503. PubMed ID: 35579419
[TBL] [Abstract][Full Text] [Related]
4. Bioengineering Novel Chimeric microRNA-34a for Prodrug Cancer Therapy: High-Yield Expression and Purification, and Structural and Functional Characterization.
Wang WP; Ho PY; Chen QX; Addepalli B; Limbach PA; Li MM; Wu WJ; Jilek JL; Qiu JX; Zhang HJ; Li T; Wun T; White RD; Lam KS; Yu AM
J Pharmacol Exp Ther; 2015 Aug; 354(2):131-41. PubMed ID: 26022002
[TBL] [Abstract][Full Text] [Related]
5. Bioengineering of a single long noncoding RNA molecule that carries multiple small RNAs.
Petrek H; Batra N; Ho PY; Tu MJ; Yu AM
Appl Microbiol Biotechnol; 2019 Aug; 103(15):6107-6117. PubMed ID: 31187211
[TBL] [Abstract][Full Text] [Related]
6. Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy.
Ho PY; Duan Z; Batra N; Jilek JL; Tu MJ; Qiu JX; Hu Z; Wun T; Lara PN; DeVere White RW; Chen HW; Yu AM
J Pharmacol Exp Ther; 2018 Jun; 365(3):494-506. PubMed ID: 29602831
[TBL] [Abstract][Full Text] [Related]
7. SIV Infection Regulates Compartmentalization of Circulating Blood Plasma miRNAs within Extracellular Vesicles (EVs) and Extracellular Condensates (ECs) and Decreases EV-Associated miRNA-128.
Kopcho S; McDew-White M; Naushad W; Mohan M; Okeoma CM
Viruses; 2023 Feb; 15(3):. PubMed ID: 36992331
[No Abstract] [Full Text] [Related]
8. Recombinant Technologies Facilitate Drug Metabolism, Pharmacokinetics, and General Biomedical Research.
Cronin JM; Yu AM
Drug Metab Dispos; 2023 Jun; 51(6):685-699. PubMed ID: 36948592
[TBL] [Abstract][Full Text] [Related]
9. APC gene is modulated by hsa-miR-135b-5p in both diffuse and intestinal gastric cancer subtypes.
Magalhães L; Quintana LG; Lopes DCF; Vidal AF; Pereira AL; D'Araujo Pinto LC; de Jesus Viana Pinheiro J; Khayat AS; Goulart LR; Burbano R; de Assumpção PP; Ribeiro-Dos-Santos Â
BMC Cancer; 2018 Oct; 18(1):1055. PubMed ID: 30376837
[TBL] [Abstract][Full Text] [Related]
10. The RNA-binding protein SART3 promotes miR-34a biogenesis and G
Sherman EJ; Mitchell DC; Garner AL
J Biol Chem; 2019 Nov; 294(46):17188-17196. PubMed ID: 31619517
[TBL] [Abstract][Full Text] [Related]
11. Alterations in Abundance and Compartmentalization of miRNAs in Blood Plasma Extracellular Vesicles and Extracellular Condensates during HIV/SIV Infection and Its Modulation by Antiretroviral Therapy (ART) and Delta-9-Tetrahydrocannabinol (Δ
Kopcho S; McDew-White M; Naushad W; Mohan M; Okeoma CM
Viruses; 2023 Feb; 15(3):. PubMed ID: 36992332
[TBL] [Abstract][Full Text] [Related]
12. Expression and Purification of tRNA/ pre-miRNA-Based Recombinant Noncoding RNAs.
Tu MJ; Wright HK; Batra N; Yu AM
Methods Mol Biol; 2021; 2323():249-265. PubMed ID: 34086286
[TBL] [Abstract][Full Text] [Related]
13. Optimized workflow to modify microRNA expression in primary human intravascular cells.
Caglayan S; Hansen JB; Snir O
BMC Immunol; 2023 Feb; 24(1):5. PubMed ID: 36792999
[TBL] [Abstract][Full Text] [Related]
14. The Optimal Outcome of Suppressing Ewing Sarcoma Growth
Li DF; Yuan Y; Tu MJ; Hu X; Li YZ; Yi WR; Li PC; Zhao Y; Cheng Z; Yu AM; Jian C; Yu AX
Front Oncol; 2020; 10():222. PubMed ID: 32161722
[TBL] [Abstract][Full Text] [Related]
15. Differential microRNA expression in the peripheral blood from human patients with COVID-19.
Li C; Hu X; Li L; Li JH
J Clin Lab Anal; 2020 Oct; 34(10):e23590. PubMed ID: 32960473
[TBL] [Abstract][Full Text] [Related]
16. Diabetes induces dysregulation of microRNAs associated with survival, proliferation and self-renewal in cardiac progenitor cells.
Purvis N; Kumari S; Chandrasekera D; Bellae Papannarao J; Gandhi S; van Hout I; Coffey S; Bunton R; Sugunesegran R; Parry D; Davis P; Williams MJA; Bahn A; Katare R
Diabetologia; 2021 Jun; 64(6):1422-1435. PubMed ID: 33655378
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential miRNA-mRNA interaction network in bone marrow T cells of acquired aplastic anemia.
Lu S; Yadav AK; Qiao X
Hematology; 2020 Dec; 25(1):168-175. PubMed ID: 32338587
[No Abstract] [Full Text] [Related]
18. The Oncogenic and Tumor Suppressive Long Non-Coding RNA-microRNA-Messenger RNA Regulatory Axes Identified by Analyzing Multiple Platform Omics Data from Cr(VI)-Transformed Cells and Their Implications in Lung Cancer.
Sweef O; Yang C; Wang Z
Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289596
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in oral fluids (saliva and gingival crevicular fluid) as biomarkers in orthodontics: systematic review and integrated bioinformatic analysis.
Kapoor P; Chowdhry A; Bagga DK; Bhargava D; Aishwarya S
Prog Orthod; 2021 Oct; 22(1):31. PubMed ID: 34632546
[TBL] [Abstract][Full Text] [Related]
20. Identification of key microRNAs associated with diffuse large B-cell lymphoma by analyzing serum microRNA expressions.
Meng Y; Quan L; Liu A
Gene; 2018 Feb; 642():205-211. PubMed ID: 29128636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
